Insider Transactions in Q3 2021 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
2,216
-2.86%
|
$24,376
$11.01 P/Share
|
|
Aug 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,216
+2.78%
|
$13,296
$6.16 P/Share
|
|
Jul 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
2,227
-2.88%
|
$26,724
$12.11 P/Share
|
|
Jul 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,227
+2.8%
|
$13,362
$6.16 P/Share
|
|
Jul 19
2021
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
21,901
-7.18%
|
$262,812
$12.02 P/Share
|
|
Jul 19
2021
|
Michael J. Kaufman Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
6,312
-16.21%
|
$75,744
$12.02 P/Share
|
|
Jul 19
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,496
-10.15%
|
$101,952
$12.02 P/Share
|
|
Jul 16
2021
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
20,043
-6.17%
|
$240,516
$12.47 P/Share
|
|
Jul 16
2021
|
Michael J. Kaufman Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
5,776
-12.92%
|
$69,312
$12.47 P/Share
|
|
Jul 16
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
7,775
-8.5%
|
$93,300
$12.47 P/Share
|
|
Jul 15
2021
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+23.53%
|
-
|
|
Jul 15
2021
|
Michael J. Kaufman Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+47.22%
|
-
|
|
Jul 15
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+30.43%
|
-
|
|
Jul 08
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+27.99%
|
$20,000
$1.4 P/Share
|
|
Jul 01
2021
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
942
-100.0%
|
$12,246
$13.6 P/Share
|
|
Jul 01
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
1,886
-5.66%
|
$24,518
$13.6 P/Share
|
|
Jul 01
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,886
+2.68%
|
$7,544
$4.84 P/Share
|